Pakistan
J. Med. Res.
Vol.
42 No.1, 2003
Radiological
presentation of pulmonary mycosis
Shafiq
Anwer, PM. Hayat Zafar, Hayat Awan,
Bahauddin
Zakrya
University University, Multan,
Pakistan.
SUMMARY
This
study was conducted over a period of
two years in Nishtar Medical College
and Hospital Mutaln. During this period
610 indoor patients suffering from
various respiratory diseases were
admitted and different laboratory
investigations, radiological
investigations and skin allergic
testing were performed and 50 patients
with repeated sputum positive for
fungus were isolated. The peak
incidence was in the age group 21-30
years. The incidence of pulmonary
myocosis is 8.2 percent and
statistically higher in male as
compared to female (P<0.01). Out of
these 50 patients 38 were males and 12
females. Further scrutiny showed that
35 had candida albicans, 11 aspergillus
and 4 mucormycosis. From the analysis
of initial signs and symptoms and their
modifications and investigations
including radiological helped us in the
diagnosis.
In
our study 4 cases of bronchogenic
carcinoma were detected and the fungus
isolated were candida and aspergillus.
Lung abscess was observed in 3 cases
and the fungus isolated was aspergillus
fumigatus. Intracavitary fungus ball
was observed and fungus isolated was
aspergillus. Bronchiectasis was
observed in 3 cases and the fungus
isolated was aspergillus niger and
candida albicans. Pneumonia was the
underlying cause in 7 cases of
pulmonary mycosis and the fungus
isolated were candida, aspergillus and
mucor. Most of the cases had pulmonary
tuberculosis and fungi isolated were
candida, aspergillus and mucor.
Profuse
growth of fungi i.e. candida,
aspergillus and mucor are described in
our study. In aspergillus profuse
growth, having a zone of haemolysis
which is characteristic feature is
described. In mucormycosis, the profuse
growth hyphae are described and in
candida characteristically spores in
magnified pictures are produced in the
study.
Out
of 35 patients having candida albicans
17 are living while 18 had died due to
associated diseases. Out of 11 cases of
aspergillosis 9 are living and 2 died.
Out of 4 cases of mucor mycosis 2 are
living, one died and one was not
traceable.
The
average prevelance was in the age 45.8±19
years. The mean survival time was 18.4±13.5
months and mean survival time of
candida, aspergillus and mucor was 16±13.7,
25.2±10.3
and 21±12.7
months respectively.
INTRODUCTION
Fungi
are simple vegetative structures; they
lack chlorophyll and cannot conduct
photosynthesis. They are characterized
by the formation of filaments or hypae,
which branch and intervene to form
dense net of growth. This mat like
growth made up of mycelium with its
spores constitutes an irregular
rudimentary plant called fungus. This
is not differentiated into roots, stems
or leaves. They are saprophytes as well
as parasites, are extremely common and
have worldwide distribution, only a few
being pathogenic. Mycosis is acquired
by inhalation of spores. They cause
primary as well as secondary infections
during the treatment of bacterial or
viral infections. They are regarded as
neither plants, nor animals but are
placed in a separate group. The fungal
infections are superficial as well as
deep. The superficial infections
involve skin; nail hands and keratin
containing structures while the deep
infections involves dermis, mouth,
bones and viscera like lungs.
Beside
tuberculosis, awareness about chest
diseases is increasing and more non-tuberculous
lung infections are being recognized
pulmonary mycosis is not uncommon;
a clinical study was undertaken in
Nishtar Medical College and hospital
Multan. The incidence of pulmonary
mycosis is 8.2% among the patients
suffering from respiratory diseases and
the incidence is higher in male as
compared to female.
Radiology
is of course has an important role in
the diagnosis of pulmonary mycotic
infection. A clinical suspicious
following a radiograph gives suspicious
of pulmonary mycotic infection. From
the analysis of initial signs and there
modifications in the course of disease,
it is possible to identify some aspects
strongly suggestive of the mycotic
nature of the pulmonary lesions like
rounded pneumonias; and hemorrhagic
infection often complicated by
cavitations with or without
intracavitary nodule are the most
suggestive aspects (Castagnone et al3).
The
radiological findings in pulmonary
aspergillosis can be homogenous
consolidation, patchy consolidation or
small circular shadows, irregular
nodular infiltrates closely resembling
pulmonary tuberculosis, and sometime a
miliary spread. A common radiographic
feature of opportunistic pulmonary
aspergillosis is a rounded cavitary
lesion with a nodule projecting into it
giving appearance like air
crescent, meniscus, target,
bulls eye or penisula. There may
be hilar lymph node enlargement.
In
blastomycosis, which tends to occur in
the upper lube, resemble bronchogenic
carcinoma; in cryptococcosis the X-ray
findings may include well-circumscribed
rounded mass or mass like densities or
pneumonia like appearance in the lower
lube.
In
histoplasmosis X-ray findings occurs as
a single or multiple areas of pneumonic
consolidation. The disease cannot be
distinguished from pulmonary
tuberculosis, nodular lesions are
scattered in both lung fields
calcification occurs in hilar lymph
nodes. Pleural involvement may occur.
Coccidiodal
pneumonia may occur and persists for
months and sometime miliary spread also
occurs. Radiologically the disease may
resemble miliary tuberculosis. There
may be cavitation with pulmonary
infiltration. Since the changes are
similar to those noted in pulmonary
tuberculosis, mycotic infection and
other chronic inflammatory diseases as
well as neoplasm, the diagnosis must be
based on mycogenic confirmation.
The
following agents are used in the
treatment of pulmonary mycotic
infections; oral drugs i.e. polyene
antibiotics, imidazole, paraentral
drugs like fluconazole; local &
parentral drugs like miconazole and
combination of antifungal therapy i.e.
quinolones and azoles.
Amphotericin
B is the only recognized antifungal
used in the treatment of mucormycosis
and the various combinations of
amphotericin B, Fluconozole and
Travofloxacin or Ciprofloxacin are
used. The combination of Fluconazole
and a Quinolone has a marked effect on
the outcome of murine pulmonary
mucormycosis. The azoles especially
fluconazole in combination with either
trofloxacin or ciprofloxacin are
effective in the treatment of mycosis
(Sugar et al 23)
The
treatment of choice with oral agents is
Ketoconazole. This drug has least side
effects and patients tolerance is
excellent. The drug is avoided in
pregnancy because of teratogenic
effect. Craig5 and Ritter20
have recommended Ketoconazole as
treatment of choice in aspergillosis.
Kohono et al13 treated one
case of aspergillosis effectively.
Maeda et al16 also treated
one case aspergillosis with
ketoconazole effectively.
MATERIAL
AND METHODS
The
cases of pulmonary mycosis were
isolated from respiratory diseases in
the department of chest diseases and
Tuberculosis, Nistar Medical college
and hospital. The study was conducted
over a period of 2 years. During this
period 610 patients suffering from
various respiratory diseases were
admitted in the chest ward and 50
patients with positive sputum for
fungus were isolated in this study. The
patients who were admitted and the
routine radiographs gave us suspicious
of mycotic infection like consolidation
without cavity or cavity having nodule
in it, lung abscess, bronchiectasis
malignancy, tuberculous infiltrations
in the lungs, and pleural effusions,
then further investigations done and
confirmation was made. Cases negative
for fungus in the sputum were excluded.
The Assessment of all these patients
was made through history, clinical
examination, X-Rays and other relevant
investigations like urine, complete
blood, blood sugar, tuberculin test,
sputum smear for AFB, skin allergic
testing, bronchoscopy & pleural
fluid cytology. A detailed history and
examination was carried out in each
case. Sputum specimen was examined for
acid-fast bacilli, cancer cells and a
culture for ordinary Micro Organism was
carried out in every case.
The specimens of sputum were
sent to the department of microbiology
for culture of the fungus. Those
patients in whom a repeated positive
culture for fungus was obtained, were
examined daily. ESR, X-Rays skiagram of
the chest was taken regularly to assess
the progress of the disease.
Apart
from sputum culture examination on
sabourauds glucose Agar and broth
media, other investigation like skin
allergic tests for various fungi,
Bronchoscopy, and in some cases pleural
fluid cytology and pleural biopsy was
done.
RESULTS
Thirty
eight men and 12 women ranged from 17
to 85 years having different types of
fungi were tabulated suffering from
respiratory diseases. Thus the
prevalence of pulmonary mycosis among
the pulmonary disease cases is 8.2
percent and this prevalence is
statistically higher in males as
compared to females (P<0.01). This
study shows that pulmonary mycosis is
present in middle and old group (more
frequently in 3rd to 7th
decades) and about 82% fall in this
range, 10% below the age of 20 years
and 6% above the age of 70 years. The
average age prevalence is 45.8 +
19 years.
Details
of cases of pulmonary mycosis
|
Age
|
Sex |
Occupation
|
Primary
Disease |
Infecting
Fungus |
|
30
years |
Male |
Shopkeeper
|
Upper
zone infiltration (Tuberculous) |
Mucor |
|
60 |
|
Farmer
|
Bronchiec
tasis |
Aspergillus
Niger |
|
85 |
|
Labourer
|
Lt.
Sided infiltration (Tuberculous) |
Candida
albicans |
|
20 |
|
Student
|
Rt.
Pneumothorax dieto (Tuberculous) |
|
|
60
|
|
Shopkeeper
|
Rt.
Upper zone infiltration (Tuberculous) |
|
|
60 |
|
Labourer
|
Malignancy
|
|
|
75
|
|
Labourer
|
Bil.
Infiltration (Tuberculous) |
|
|
70 |
Female |
Household |
Bil.
Pneumonia |
|
|
80 |
|
Household
|
Malignancy
|
|
|
22 |
Male |
Labourer
|
Rt.
Sided infiltration (Tuberculous) |
|
|
50 |
|
Hawker
|
Malignancy
with pleural effusion |
|
|
40 |
Female
|
Household
|
Bil.
Infiltration (Tuberculous) |
|
|
40 |
Male |
Chowkidar
|
Rt.
Pneumonia |
Mucor |
|
55 |
|
Labourer
|
Rt.
Upper zone infiltration (Tuberculous) |
|
|
70 |
Female |
Farmer
|
Lt.
Sided infiltration (Tuberculous) |
|
|
30 |
Male
|
Labourer
|
Rt.
Sided cavitary lesion |
Asp.
Fumigatus |
|
60 |
|
Carpenter
|
Lung
abscess right |
|
|
38 |
|
Servant
|
|
|
|
21 |
|
Labourer
|
Rt.
Upper zone infiltration (Tuberculous) |
|
|
25 |
|
Student
|
Bronchitechtasis
|
|
|
25
|
|
Vegetable
seller |
Bil.
Infiltration (Tuberculous) |
|
|
65 |
|
Mason |
Lung
abscess right |
|
|
40 |
|
Shopkeeper
|
Mediastinal
growth |
|
|
65 |
Female |
Household |
Pneumona
Rt. |
|
|
55 |
|
|
Rt.
Upper cavitary lesion (Tuberculous) |
|
Table
1:
Distribution of fungi in
relation with different diseases
---------------------------------------------------------------------------------------
Candida
Aspergillosis
Mucor-
---------------------------------------------------------------------------------------
Pulmonary
Tuberculosis
24
2
3
Pneumonia
3
3
1
Malignancy
3
1
-
Lung
abscess
-
3
-
Bronchiectasis
1
2
-
Hydatid
cyst
1
-
-
COPD
1
-
-
Cystic
lung
disease
1
-
-
Eosinophilia
1
-
-
_________________________________________________________
This
table shows that pulmonary tuberculosis
was more prominent disease, in 24
patients candida was recovered, and in
2 aspergillosis and in 3 mucor
detected. Pneumonia was underlying
cause in 3 cases of candida albicans
infection, 3 cases of aspergillosis and
one case of mucor mycosis. Lung
malignancy was underlying cause in 3
cases of candida infection and one case
of aspergillosis. Lung abscess was
cause in 3 cases of aspergillosis.
While bronchiectasis was underlying
cause in 2 cases of aspergillosis and 1
case of candida albicans. Hydatid cyst,
COPD; cystic lung disease, Eosinophilia
was underlying cause in candida
infection.
Pleural
effusion was detected in 6 (12%)
patients. All were from candida
albicans series. There were 4(8%) cases
of pulmonary tuberculosis while in 2
(4%) cases the cause was lung
malignancy.
Out
of 35 cases of pulmonary candidiasis
17(48.57%) were living and 18(51.43%)
were dead, out of 11 cases of pulmonary
aspergillosis 9(81.81%) were living and
2 (18,18%) died while out of 4 cases of
mucormycosis 2(50%) were living, 1(25%)
died and 1(25%) was not traceable.
Table
2:
Causes of Death
----------------------------------------------------------
Candida
Aspergillosis
Mucor
---------------------------------------------------------------------------------------
Pulmonary
Tuberculosis
15
0
1
Lung
Abscess
0
1
0
Pneumonia
1
1
0
Lung
malignancy
2
0
0
_________________________________________________________
Table
3:
Percentage of Alive/Expired
patients of different types of
pulmonary mycosis
---------------------------------------------------------------------------------------
Alive
Expired
Not Traceable
---------------------------------------------------------------------------------------
Candida
17(48.57%)
18(51.43%)
--
Aspergillosis
9(81.81%)
2(18.19%)
--
Mucor
2(50%)
1(25%)
1(25%)
______________________________________________
DISCUSSION
Figure
1 and 2 show Bronchogenic Carcinoma. In
this study 4 cases of Bronchogenic
Carcinoma were detected and the fungus
isolated was Cadida Albicans, also
observed from Japan in Shimuzu et al22
series in 1993, bronchogenic carcinoma
was associated with pulmonary Mycosis. Eight cases of
pulmonary mycosis were evaluated in
immuno-compromised patients in 1997 in
Japan and the underlying diseases were
lung cancer, post bone marrow
transplant, Aids, and bronchial asthma.
Urakaming etal26.
Figure
3 and 4 present with lung abscess and 3
cases were observed in our study. In
Tedder et al25 study from
North Carolina the pulmonary mycosis
was associated with lung abscess.
Figure 5 shows extensive advanced
pulmonary tuberculoses with bilateral
cavitary lesion. The fungus candida
albicans, aspergillus and mucor were
isolated in pulmonary tuberculosis. The
parenchymal lesion may lead to
fibrosis, cavitations or granulomatous
nodules. There are frequently hilar
lymph node involvement and occasionally
pleural involvement occurs. In our
series pleural effusion was detected in
6 cases, 4 from candida series and the
underlying cause was pulmonary
tuberculosis and in 2 cases the cause
was lungs malignancy which is in
agreement with Kado et al12.
Figure
6 and 7 show intra cavitary fungus
ball, observed in our study and the
fungus isolated were aspergillus
fumigatus. Figure 8 represents hydated
cyst, being underlying cause and the
fungus isolated was candida albicans.
Figure 9 represents bilateral
bronchiectasis, observed in 3 cases in
our series, the fungus isolated was
aspergillus and candida and this was
also observed by Niki et al18
and Chern et al4. Figure 10
and 11 show magnified growth of candida
albicans.
Pneumonia
was underlying cause in 7 cases of
pulmonary mycosis in our study, 3 from
candida, 3 from aspergillosis and 1
from mucormycosis which has been also
described by Bundgaard et al2,
Lake et al14 and Tedder et
al25. Fig. 12 shows profuse
growth of mucormycosis. Figure 13 shows
growth of aspergillus.
Pulmonary
and extra pulmonary manifestations of
aspergillosis, histoplasmosis and
blastomycosis are reviewed in a paper
published in 1997 (Urakaming et al26)
showing fungal pneumonias and is in
agreement in our study having pneumonia
presentation in 7 cases.
A
common radiographic feature of
opportunistic pulmonary aspergillosis
is a rounded cavitary lesion with a
nodule projecting into it. This
appearance has been given a variety of
names including Air Crescent,
Meniscus, Target, and Bulls eye. And
Penisula (Gross et al9,
Gefter7 and Bolton et al1.
In our study one case of aspergilloma
cavity having fungus ball is
detected. The fungus isolated was
aspergillus fumigatus. Radiological
features of invasive pulmonary
aspergillosis observed in 20 patients
were reported in Italy in 1984 by
Castagnone et al3, Wang et
al28 and McCaffery et al15.
From the analysis of initial signs and
there modifications in the course of
disease, it was possible to identify
some aspects strongly suggestive of the
mycotic nature of the pulmonary
lesions, like rounded pneumonia and
hemorrhagic infarction often
complicated by cavitation with or
without intracavitary nodule are the
most suggestive aspects (Castagnone et
al3). In our study 11 cases
of pulmonary aspergillosis are
detected. Also presentation like
pneumonia, lung abscess, bronchiectasis
and lung cancer is described. Chest
X-ray findings of aspergillosis is of
two types: one was an air crescent sign
which was noted in recovery phase from
leukaemia and the other was gradually
enlarging consolidation and progressed
to labor pneumonia (Fugishitan et al6).
In our study air crescent with fungal
ball is observed in aspergillus
infection.
The
roentgenologic pattern of the pulmonary
manifestation of candida species
resulting in a rapid development of
pulmonary cavitation with mycetoma-structures
was described by Rix21 1987
in 3 patients. This type of pattern by
candida was not observed in our study.
AIDS predisposes to pulmonary mycosis
(Jones et al11, Perrin et al19,
Minamoto et al17 and Ritter20.
A
59 years old woman with diabetes
mellitus and rheumatoid arthritis was
started prednisolone and she developed
fever and bloody sputum and x-ray chest
showed a massive shadow in the right
lower lung filed. Aspergillus hyphae
were detected from the bronchial
brushing and pulmonary aspergillosis
was diagnosed. Pneumonia like
presentation is observed in our study,
which is in agreement with Wakayama et
al27.
Invasive
pulmonary aspergillosis (IPA) in the
presence of hamatologic malignancies is
increasingly common condition
characterized by high morbidity and
mortality. Plain chest films are a
valuable tool for diagnosis but the
radiologist must be familiar with the
morphological features of the disease
to interpret radiographic abnormalities
of (IPA) from opportunities pneumonia (Zizzo
et al29).
Association
of pulmonary mycosis with other
diseases has been reported from the
various countries like Japan in Shimuzu
et al22 series, and the
bronchogenic carcinoma was associated
with pulmonary mycosis and in Italy
Taviani et al24 series the
pulmonary mycosis was associated with
lymphatic leukaemia. In Tedder25
series from North Carolina, pulmonary
mycosis was associated with lung
abscess.
A
case of pulmonary candidiasis occurred
during therapy for tuberculosis
pleurisy (Kado et al12), in
our series pleural effusion was
detected in 6 cases from candida
series, and the underlying cause was
tuberculosis and lung malignancy.
Allergic
bronchopulmonary aspergillosis, an
uncommon but potentially destructive
aspergillus associated pulmonary
disease is characterized by recurrent
episodes of pulmonary infiltrations and
central bronchiectasis and may lead to
irreversible fibrosis Niki et al18,
Chern et al4.
In
our series in 3 cases of bronchiectasis
are detected, the fungus isolated was
aspergillus and candida albicans.
Coccidiodal
pneumonia may occur and persist for
months. Sometime miliary spread may
occur. Radiologically the disease may
resemble tuberculosis and there may be
cavitation. In histoplasmosis x-ray
findings occur as single or multiple
areas of pneumonic consolidation. The
disease cannot be distinguished from
pulmonary tuberculosis. Nodular lesions
are scattered in both lung fields.
Calcification may occur in hilar lymph
nodes. Pleural involvement may occur.
In our study coccidiomycosis and
histoplamosis were not observed. In
cryptococcosis the x-rays findings
include well-circumscribed rounded mass
or mass like densities or pneumonia
like appearance in the lower lobes. In
mucor mycosis the lesions like
aspergillus may occur but less
prominent. In chronic form of
blastomycosis, the lesion resembles
pulmonary tuberculosis. There is
fibronodular appearance consist of a
linear fibrotic strands and sometime
mass like appearance which can resemble
bronchogenic carcinoma. In our study,
cryptococcosis, histoplasmosis are not
detected. Pneumonia described by Niki
et al18 one case, Castagnone
et al3 20 cases, Herbert et
al10 one case, Greene et al8
one case, Ritter et al20
which was also observed in 7 cases of
our study.
In
our study 50 patients had pulmonary
mycosis of different types out of these
50 patients, 38 were males and 12
females, 35 had candida albicans, 11
aspergillosis and 4 mucor mycosis. The
incidence was 8.2% among the
respiratory diseases and statistically
higher in male as compared to female
(P<0.01). The age incidence was from
3rd to 7th decade
and the mean age in female was higher
as compared to female.
Average
prevalence was in the age 45.8 +
19 years. Invasive pulmonary
aspergillosis in hamatologic
malignancies is increasingly common and
chest radiographs are valuable tool for
diagnosis for early interpretation and
latter confirmation of mycosis. Thus
decreasing the morbidity and mortality.
The mean survival time was 18.4 +
13.5 months. Mean survival time of
candida, aspergillus and mucor was 16 +
10.3; 25.2 + 10.3, 21 + 12.7
month respectively.
CONCLUSIONS
In
this study, 50 patients with pulmonary
mycosis of different types were
isolated from 610 patients suffering
from different respiratory diseases.
Out of these 50 patients, 38 were males
and 12 females. Further scrutiny showed
that 35(70%) had candida albicans,
11(22%) aspergillosis and 4(8%)
mucormycosis among the respiratory
disease cases was 8.2 percent and the
prevalence was higher in male as
compared to female.
Radiology
has important role in the diagnosis of
pulmonary mycotic infection. A clinical
suspecious following a radiograph give
suspecious of pulmonary mycotic
infection and moreover early suspecious
and confirmation may reduce the
morbidity and mortality of pulmonary
mycotic infection but the radiologist
must be familiar with the morpholigical
features of the disease to interpret
radiographic abnormalities.
|
|
|
|
|
|
|
|
|
|
|
REFERENCES
Bolton-JW,
Lazaz-HL. Internal closure of
aspergilloma cavity. South Med J
1993; 86(11): 1286 91
Bundgaard
A, Schonheyder H, Bech JP. Pulmonary
aspergillosis with abscess formation. Vegeshv-Laeger
1983; 145 (26); 2029 30.
Castagnone
D, Radaelli P, Cortelezzi A.
Radiological aspects of invasive
pulmonary aspergillosis. Radial
Med-(Jornia) 1984; 70 (1-2) 1-6.
Chern-JH,
Chen-CH, Lee-yc, Chern-MS., Allergic
broncho pulmonary aspergillosis. Chung-Hua-I-Hsuch-Tsa-Chin-Taipei
1994; 53(3): 179-84.
Craig
RC, Stitzel ER. Modern pharmacology.
4th edition. USA: Little
Brown, 1994
647 56
Fujishita
M, Kataoka R, Kobayashi M, Miyoshi I.
Clinical Features of 32 cases of fungal
pneumonia. Nippon Kyobu
Shikkan Gakkai Zaashi 1991;
29(4);
420-8.
Gefter
WB.
The spectrum of pulmonary
aspergillosis.
J-Thorac-Imaging 1992; 1 7
(4): 56-74
Greene
R. The pulmonary aspergillosis. Three
distinct entities or a spectrum of
disease. Radiology 1981; 140 (2):
527 30
Gross
B.H; Spitz H.B; Falson B. The mural
nodule in cavitary opportunistic
pulmonary aspergillosis. Radiology
1992; 143(3); 619 22.
Herbert
PAand Bayer A. Fungal Pneumonia:
invasive pulmonary aspergillosis.
Chest
1981; 80 (2) : 220-5.
Jones
PG, Cohen RL, Batts DH, Silva JJr.
Disseminated histoplasmosis, invasive
pulmonary aspergilloma in a homosexual
with AIDS. Transm Dis(1993);
10(4): 202-4.
Kado
M; NishiKawa-S; Oshima-S; Sugimoto-K. A
case of pulmonary candidiasis occurred
during therapy for tuberculous. Pleurisy
Kekkaku 1979; 54(7) : 407-11.
Kohono
S; Koga I.I.(1993)
Pulmonary mycosis without
underlying systemic disease,
int. Med ., 32(12): 932 4
Lake
FR, Mc Aleer R, Tribe AE.
Pulmonary mucor mycosis.
Med J 1988; 19; 149(6): 323
6.
McCaffrey
J, Demos TC.
Pulmonary aspergillosis. Inf:
1993; 161 (3): 163, 203 6.
Maeda
T. A case of chronic narcotizing
pulmonary aspergillosis effectively
treated by miconazole inhalation. Nippen
Kyoby-Shikken-Gakkai-Zasshi
1994;32(2):168 71
Minamoto
GY, Barlam.TF, Vander NJ. Invasive
pulmonary aspergillosis in patients
with AIDS. Clin Infect
Dis 1992; 14(1): 66 74.
Niki
Y, Yashiguchi K, Tamada S, Toshida K,
Sugimura S, Nakajima M. A case of
aspergillus Niger Pneumonia. Kansen
Shogaku Zasshi 1994; 68(6) 789
91.
Perrin
C, Taillan B, Heuvdier P, Hofman P,
Fuzibet JG, Dujardin P.
Invasive pulmonary aspergillosis
in AIDS.
Press
Med 1992; 21(32): 1532 3.
Ritter
MJ, Lewis DL, Mant G K. Clinical
pharmacology. 3rd
edition. London: Edward Arnold
Publication 1995: 552 7.
Rix
E, Bickel RH, Baldauf G. Pulmonary
Candia in immuno- compromised patients.
Radiology 1997; 27(1); 25-8.
Shimuzu
Y, Watanaba Y, Oda M, Watanaba S,
Hayashi Y, Iwa T, et al. A case of lung
cancer suspected to be pulmonary
mycosis of the fungus ball type. Nippon
Kyobu Shikkan Gakkai
Zaashi 1993; 28(9): 1252 6.
Sugar
AM, Liu XP. Combination antifungal
therapy in the treatment of murine
pulmonary mucormycosis. Role of
quinolone and azoles. Antimicrob
Agents Chemother 2000; 44(7): 2004-6.
Taviani
M. LoCasto R.M, Verna A, Brigli G,
Cariati E. The surgical treatment of
pulmonary mucor mycosis.
Minerva-Chir 1993; 30; 48(8):
435-7.
Tedder
M, Spartz J, Anstadt MP, Hegde SS,
Tedder SD, Lowe JE. Pulmonary mucor
mycosis. Ann Thoroc Surg 1994; 57(4)
: 1044 50.
Urakamig
R, Nagasaki Y, Tohda Y, Ohishi M,
Nakajima S, Fukuoka M. The clinical
features of eight cases of
opportunistic fungal pneumonia. Kansenshigaku-Zaashi,
1997; 71(1): 65-71
Wakayama
H, Itoh Y, Noguchi M, Kawaguchi H,
Ohshika H, Suzuki M, et al. Successful
Surgery for pulmonary aspergillosis in
sub acute process. Nippon Kyobu
Shikkan Gakkai Zasshi 1993;
31(12): 1572-7.
Wang
GX. The Roentginologic diagnosis of
pulmonary mycosis.
Chung-Hua- Chick Ho
Ho Hu His Chi Ping
Tsa Chik 1993; 8(4): 215 7.
Zizzi
G, Melillo L, Cammisa M, Carotenuto M.
Invasive pulmonary asergillosis. Radiol
Med Torino1994; 87 (4): 435 40.